Leveraging undiscovered biological networks in age-related diseases

Company logo

Company logo

Dublin, June 17, 2022 (GLOBE NEWSWIRE) – The “Growth Opportunities in Predictive Genetic Testing, AI Drug Discovery, Circular RNA, and Advanced Drug Delivery” Report added to ResearchAndMarkets.com Show.

The report focuses on technology platforms that leverage artificial intelligence and machine learning algorithms to discover new targets and applications for drug development. The main focus of this issue is on accurate tumor testing and other predictive genetic testing for multiple therapeutic applications. In particular, technologies that enable early diagnosis of cancer, support discovery of vital signs and pathological prognosis are covered.

Another focus of this issue is on advanced RNA therapies, including circRNAs and self-replicating RNAs that provide many advantages to conventional RNA-based therapies. Additionally, advanced drug delivery has been recorded using engineered cells and biosensors to monitor treatment efficacy and response.

The report presents disruptive technological developments in the global life sciences industry. The technologies and innovations on display will include advances across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among many other platforms.

The Health and Wellness Group tracks advances in a myriad of fields including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, management and treatments for pain and disease, drug delivery, personalized medicine, and smart healthcare.

Main topics covered:

1. Innovations in life sciences, health and wellness

  • Machine learning (ML) model based on cellular in vitro systems for drug discovery and development

  • Determine disease-modifying goals

  • Insitro – Investor Dashboard

  • Generating AI-driven microdisease models to develop targeted therapies

  • Generate accurate modeling of specific diseases

  • Genome Biology – Dashboard

  • Leveraging undiscovered biological networks in age-related diseases

  • Using Omics data to track aging

  • BioAge Labs – Investor Dashboard

  • Using small RNA (sRNA) signatures to provide insights into target pathways for drug development

  • Treating chronic degenerative diseases

  • Gatehouse Bio – Investor Dashboard

  • RNA-based synthetic circular therapies

  • A promising alternative to traditional mRNA

  • Orna Therapeutics, Inc. Investor control panel

  • The srRNA platform prevents the emergence of drug resistance in cancer

  • srRNA enables expression of a sustained therapeutic protein

  • Replicate Bioscience – Investor Dashboard

  • Programmable circular RNA therapies

  • One treatment serving multiple disease areas

  • Laronde – Investor Dashboard

  • Next-generation sequencing-based tests for genetic disorders

  • Whole exome sequencing Identification of DNA variants

  • Berry Genomics – Investor Dashboard

  • Microtumor Health Intelligence Platform

  • Technique enabling comprehensive panel for profiling cancer

  • Sema4 Opco, Inc. Investor control panel

  • Red blood cell-based platform stimulates immune system to protect against COVID-19

  • Technology Value Proposition for McMaster University

  • Nanoparticles coupled with regulatory proteins to evade immune system attacks to deliver nanoparticles

  • Technology Value Proposition for University of Pennsylvania

  • Advanced tool for accelerating crop genomic testing

  • Technology value presentation from CABI

  • Evaluation of immunological blockade (ICB) therapy for cancer using biosensors

  • Technology Value Proposition for Georgia Institute of Technology

mentioned companies

  • Berry Genomics

  • BioAge Laboratories

  • capy

  • Gatehouse Bio

  • genome biology

  • Instro

  • La Rond

  • Orna Therapeutics, Inc.

  • Biological science replication

  • Sema4 Opco, Inc.

For more information on this report visit https://www.researchandmarkets.com/r/jc331h

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, major companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900